CEA was described as an endogenous receptor for GAL-1, GAL-3, and GAL-4 in human colon carcinoma cells and in colon carcinoma liver metastasis (68, 72, 126, 127, 163). The gene discussed is LGALS1; the disease is colon carcinoma.